Kingfisher Capital LLC Abbott Laboratories Transaction History

Kingfisher Capital LLC

$428 Million
Q3 2024

A detailed history of Kingfisher Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kingfisher Capital LLC holds 41,004 shares of ABT stock, worth $5.29 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

41,004

Previous 44,059 6.93%

Holding current value

$5.29 Million

Previous $4.58 Million 2.1%

% of portfolio

1.09%

Previous 1.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $305,713 - $360,887	-3,055 Reduced 6.93%	41,004 $4.67 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $48,854 - $54,533	-485 Reduced 1.09%	44,059 $4.58 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $325,055 - $359,009	-2,968 Reduced 6.25%	44,544 $5.06 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $1.68 Million - $2.05 Million	-18,585 Reduced 28.12%	47,512 $5.23 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $45,185 - $54,215	473 Added 0.72%	66,097 $6.4 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $108,136 - $120,487	-1,073 Reduced 1.61%	65,624 $7.15 Million
Q1 2023 May 02, 2023	BUY	$96.86 - $114.01 $25,958 - $30,554	268 Added 0.4%	66,697 $6.75 Million
Q4 2022 Jan 19, 2023	BUY	$95.06 - $111.52 $978,642 - $1.15 Million	10,295 Added 18.34%	66,429 $7.29 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $390,329 - $451,929	4,034 Added 7.74%	56,134 $5.43 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $312,844 - $378,129	3,065 Added 6.25%	52,100 $5.66 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $92,242 - $112,483	809 Added 1.68%	49,035 $5.8 Million
Q4 2021 Jan 25, 2022	BUY	$115.53 - $141.46 $359,182 - $439,799	3,109 Added 6.89%	48,226 $6.79 Million
Q3 2021 Oct 29, 2021	BUY	$116.66 - $129.06 $154,924 - $171,391	1,328 Added 3.03%	45,117 $5.33 Million
Q2 2021 Aug 03, 2021	BUY	$105.79 - $124.53 $176,880 - $208,214	1,672 Added 3.97%	43,789 $5.08 Million
Q1 2021 May 07, 2021	BUY	$108.84 - $128.23 $250,332 - $294,929	2,300 Added 5.78%	42,117 $5.05 Million
Q4 2020 Jan 28, 2021	BUY	$105.0 - $114.42 $308,805 - $336,509	2,941 Added 7.98%	39,817 $4.36 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $152,947 - $185,743	1,669 Added 4.74%	36,876 $4.01 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $31,699 - $40,572	414 Added 1.19%	35,207 $3.22 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $42,089 - $61,546	-670 Reduced 1.89%	34,793 $2.75 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $26,222 - $29,191	334 Added 0.95%	35,463 $3.08 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $7,365 - $7,986	90 Added 0.26%	35,129 $2.94 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $59,397 - $69,275	-815 Reduced 2.27%	35,039 $2.95 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $97,740 - $118,168	-1,476 Reduced 3.95%	35,854 $2.87 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $8,785 - $9,952	-134 Reduced 0.36%	37,330 $2.7 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $21,648 - $26,116	356 Added 0.96%	37,464 $2.75 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $9,959 - $10,992	173 Added 0.47%	37,108 $2.26 Million
Q1 2018 May 16, 2018	SELL	$56.27 - $63.62 $90,088 - $101,855	-1,601 Reduced 4.15%	36,935 $2.21 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $61,517 - $65,860	-1,146 Reduced 2.89%	38,536 $2.2 Million
Q3 2017 Nov 06, 2017	SELL	$48.06 - $53.64 $61,084 - $68,176	-1,271 Reduced 3.1%	39,682 $2.12 Million
Q2 2017 Aug 15, 2017	BUY	N/A	40,953	40,953 $1.99 Million

Others Institutions Holding ABT

# of Institutions

3,247

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingfisher Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingfisher Capital LLC with notifications on news.

Account

Kingfisher Capital LLC Abbott Laboratories Transaction History